Thyroid treatment may prevent heart disease in diabetics

Image
Press Trust of India New York
Last Updated : Jun 26 2014 | 4:11 PM IST
Restoring thyroid hormones in heart may prevent cardiovascular disease resulting from diabetes, according to a new study.
Administering low doses of a thyroid hormone to rats with diabetes helped restore hormone levels in their hearts and prevented deterioration of heart function and pathology, researchers said.
The study by New York Institute of Technology (NYIT) College of Osteopathic Medicine professor A Martin Gerdes provides the first clear indication that low thyroid hormone levels in cardiac tissue of diabetic individuals may be the major cause of their associated heart disease.
The study finds that diabetes triggers low thyroid levels that contribute to heart failure.
In animal models, Gerdes and colleagues found that administering low doses of the active form of thyroid hormone, T3, prevented the progression of heart disease.
"This treatment prevented the abnormal changes in gene expression, tissue pathology, and heart function," said Gerdes.
"The clinical implications are profound and far-reaching because it suggests that the heart disease associated with diabetes may be easily preventable," Gerdes said.
"And importantly, the dose we gave of T3 hormone did not significantly change the serum (blood) thyroid hormone levels but it was enough to make all the difference in the heart tissue," Gerdes said.
An individual's thyroid levels are usually measured by blood tests. But Gerdes has noted that thyroid hormone levels in cardiac tissue do not necessarily correspond with blood test readings of thyroid levels.
His research has consistently found that low-dose thyroid hormone replacement may be a safe and effective therapy to help humans suffering from heart disease.
"A low thyroid condition can cause heart failure by itself," said Gerdes.
In his animal study, Gerdes and colleagues induced a mild form of diabetes in rats and waited a month for the condition to develop. They then administered low doses of T3 hormone for two months.
The study was published in the journal Molecular Medicine.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 26 2014 | 4:11 PM IST

Next Story